Andrew Lim

Andrew Lim obtained his PhD from the University of Dundee, working on an antibacterial drug discovery project. He then proceeded to work as a Postdoctoral Researcher in Drug Discovery in a project funded by the Tres Cantos Open Lab Foundation, in which he represented the academic partner Oxford Clinical Research Unit based in Vietnam to work in an academic-industrial collaborative project on the development of an intracellular assay in GSK Tres Cantos research site in Spain. He later joined the ALBORADA Drug Discovery Institute in 2020 as the Assay Development and Screening Scientist working on neurodegenerative diseases.